| Pathway | Gene counts | P-value |
| Pathways in cancer | 45 | 9.82E−30 |
| Hepatitis B | 31 | 6.98E−28 |
| Bladder cancer | 18 | 9.06E−22 |
| Prostate cancer | 22 | 6.38E−21 |
| Pancreatic cancer | 18 | 8.42E−18 |
| Small cell lung cancer | 19 | 5.11E−17 |
| Chagas disease (American trypanosomiasis) | 20 | 1.20E−16 |
| TNF signaling pathway | 20 | 2.10E−16 |
| HIF-1 signaling pathway | 19 | 5.10E−16 |
| Non-small cell lung cancer | 16 | 5.57E−16 |
| Influenza A | 22 | 1.65E−14 |
| Proteoglycans in cancer | 23 | 2.55E−14 |
| Colorectal cancer | 15 | 7.84E−14 |
| Toxoplasmosis | 18 | 1.09E−13 |
| Hepatitis C | 19 | 2.06E−13 |
| p53 signaling pathway | 15 | 2.49E−13 |
| Chronic myeloid leukemia | 15 | 7.18E−13 |
| Toll-like receptor signaling pathway | 17 | 9.02E−13 |
| Glioma | 14 | 3.44E−12 |
| HTLV-I infection | 23 | 3.57E−12 |